BIOSYNTIA ApS
Core data
Name | BIOSYNTIA ApS |
Address | Fruebjergvej 3, 2100, København Ø |
Founded | Dec 19, 2012 |
Employees (CVR) | 12 |
Locations (P-units) | 1View locations |
Website | https://www.biosyntia.com/ |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Name | BIOSYNTIA ApS |
Address | Fruebjergvej 3, 2100, København Ø |
Founded | Dec 19, 2012 |
Employees (CVR) | 12 |
Locations (P-units) | 1View locations |
Website | https://www.biosyntia.com/ |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Keep track of BIOSYNTIA ApS
Description
Biosyntia is a product company that produces natural ingredients through proprietary microbial fermentation processes, focusing on fermented vitamins and plant-derived bioactives.
Biosyntia develops and integrates engineered microorganisms and fermentation processes to produce dietary ingredients at commercial scale. Its activities include strain engineering, fermentation optimization, bioprocess development, downstream process development, scale-up, quality control, regulatory filing and commercial-scale production.
Company's own description on virk.dk
Primary activities Selskabets aktiviteter består i forskning, udvikling og produktion af biobaserede ingredienser, The company's activities comprise research, development and production of bio-based ingredients..
Products & services
Natural ingredients produced through microbial fermentation · Fermented vitamins · Plant-derived bioactives · Natural functional ingredients · Biosynthetic Selections™ technology · Fermentation optimization · Bioprocess development · Downstream process development · Scale-up · Quality control · Regulatory filing · Commercial-scale production
Industries
Biotechnology · Natural ingredients · Dietary ingredients · Fermented vitamins and plant-derived bioactives
Customer types
Personal care product companies · Dietary supplement companies · Food and beverage companies · Animal-free food companies
Financials
| Reporting period | 2025DKK | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross profit | -14,222,601 | ||||||||
| Operating profit | -24,858,037 | ||||||||
| Profit before tax | -24,926,492 | ||||||||
| Net income | -20,066,332 | ||||||||
| Total assets | 44,294,211 | ||||||||
| Equity | 32,860,576 | ||||||||
| Avg. employees | 12 | ||||||||
2017–2025 Unlock financial history | |||||||||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Contact
From biosyntia.com
| Contact | Phone | |
|---|---|---|
| Main | — | he***@biosyntia.comShow full |
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
People
| Person | Roles | Titles |
|---|---|---|
| Henrik Dalbøge | Roles Board | TitlesFORMAND |
| Thomas Grotkjær | Roles Board | TitlesBESTYRELSESMEDLEM |
| Martin Plambech | Roles Management | TitlesADM. DIR. |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| Beierholm | AuditorLouise Corneliussen | RoleStatsaut. revisor | FromJul 8, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
| Ownership33.33–49.99 % | Voting rights33.33 % | FromJun 20, 2022 | |
Unknown Other Participant | Ownership25–33.32 % | Voting rights25 % | FromJun 20, 2022 |
| Ownership10–14.99 % | Voting rights10 % | FromApr 1, 2023 | |
Unknown Other Participant | Ownership10–14.99 % | Voting rights10 % | FromJun 20, 2022 |
Unknown Other Participant | Ownership5–9.99 % | Voting rights5 % | FromSep 30, 2022 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| NOVO NORDISK FONDEN | Ownership through | 33.33–49.99 % |
| 🇫🇷Sofinnova Industrial Biotech I | Ownership through Direct | 25–33.32 % |
| Danmarks Eksport- og Investeringsfond | Ownership through Direct | 10–14.99 % |
| 🇱🇺ECBF I SCSp | Ownership through Direct | 10–14.99 % |
| 🇱🇺Praesidium S.C.A. SICAV-RAIF | Ownership through Direct | 5–9.99 % |